courseware solutions |
||||||
|
News for 01-Apr-25 Source: MedicineNet Diabetes General Source: MedicineNet Diabetes General Source: MedicineNet High Blood Pressure General Source: MedicineNet High Blood Pressure General Source: MedicineNet Diabetes General Source: MedicineNet Diabetes General Source: MedicineNet High Blood Pressure General Source: MedicineNet High Blood Pressure General Source: MedicineNet Diabetes General Source: MedicineNet Diabetes General
|
The Best courseware solutions websiteAll the courseware solutions information you need to know about is right
here. Presented and researched by http://www.mdnewscast.net. We've searched
the information super highway far and wide to provide you with the
best courseware solutions site on the internet today. The links below will
assist you in your efforts to find the information that you are looking
for about
courseware solutions
The following link will take you to a great courseware solutions supplier who can help you with exactly what you need. Of course if you just can't get enough courseware solutions information then keep on browsing AFTER you add this page to your favourites. Why? Because when you finally get sick of browsing through the rubbish for courseware solutions you'll want to get back here as quickly as possible so you can find the courseware solutions information you were after in the first place. So if you are serious about finding great courseware solutions information, add us to your favourites or click the above link right now. courseware solutions
Customer testimonials are a clear indication that a courseware solutions website is doing a good job. People who have purchased courseware solutions and received their goods in a prompt and efficient manner are the best advertising a business can have. In short they are saying **Buy your courseware solutions here**. Long established highly reputable courseware solutions suppliers will even provide a contact link so that you can talk directly with the customer. This means that they are so confident that their courseware solutions customer has had a good experience that they are prepared to put you in direct contact with them. Ultimately it will be your courseware solutions shopping experience that determines how happy you are with the supplier. We'd like to think of ourselves as intermediaries to ensure that your courseware solutions shopping experiences are positive ones. Our website is full of solid evidence backing up the shopping links shown above. a Cold; Starve a Tumor by: ARA Content
(ARA) - One of the most exciting developments in modern medicine has been the discovery that cancerous tumors have the potential of being "starved" out of existence, or at least into dormancy. Scientists, doctors and, of course, patients, are all anticipating the prospect that cancer patients may take a drug that will stop a tumor in its track by cutting off the blood supply that nourishes it. At the core of this medical breakthrough was the discovery that every tumor needs to "recruit" its own blood supply to flourish and grow. Scientists also found out that tumors actively "participated" in this process by secreting certain growth chemicals that would attract blood vessels to the tumor. Having identified this process, the next step was to determine if drugs could be created that could somehow arrest or reverse the progress of blood vessels amassing around a tumor. The result has been a highly dynamic and exciting area of medicine called anti-angiogenesis (meaning "against the formation of new blood vessels") that focuses on inhibiting the growth of cancer by developing drugs that will prevent tumors from growing in size. Currently, there are several drug companies that are on the cusp of introducing drugs that will work by the process of anti-angiogenesis. Generally speaking, the drugs seek to improve survival rates of cancer patients, as well as increase the length of time that patients survive. And unlike conventional cancer therapies that have punishing side effects, the new drugs seem to demonstrate few or no side effects for most people. Furthermore, some of the studies show that by utilizing both conventional treatments like radiation and/or chemotherapy in conjunction with anti-angiogenesis drugs, the cumulative effect is even more powerful. One highly regarded company that is at the forefront of developing anti-angiogenesis drugs is Aeterna Laboratories, based in Quebec, Canada and traded on the Nasdaq market under the ticker symbol, AELA. The company's premier product, Neovastat, is currently being tested in clinical trials for a variety of cancers including lung, renal (kidney) and multiple myeloma (bone marrow). The results for the renal and multiple myeloma tests are scheduled to wrap up by the end of 2002 and, if conclusive, will be submitted to the Federal Drug Administration for review. Out of all the drugs under development, Neovastat is unique because of its multi-functionality, which is its ability to shut down two pathways recognized as being responsible for promoting angiogenesis (in contrast to other drugs which just block one pathway). In clinical trials, Neovastat has been shown to have no side effects in most people. This is obviously a big advantage for people who know the agony of nausea, exhaustion and/or hair loss that can accompany chemotherapy drugs. In tests, Neovastat has been given to people in liquid oral form, generally the preferable form of drug delivery for patients. If you are a cancer patient interested in clinical trial participation, you can get information about current trials by calling (888)-349-3232 If you are an oncologist, please contact Claude Hariton, Ph.D., vice president of Clinical and Regulatory Affairs at (418) 652-8525 ext. 306. To learn more about anti-angiogenesis drugs and Aeterna Laboratories, visit the Aeterna Web site at www.aeterna.com.
|
|||||
|
http://www.medmeet.com/ |
||||||
| Medical Newscast Present On The Net Medical Meetings On The Net |